NRC

NEUTRALEarnings

National Research Corporation

2026-09-08

Price

$21.19

+3.67%

This is the 2026-09-08 snapshot — the signals and analysis for NRC as of this single trading day.

View full NRC research hub →

Score9.5Priority

Signals3/8 DNA2/13 Act · 0/4 Risk

SentimentNEUTRALScore: 7

Volume1.3xvs 20d avg

Analysis

NRC Health is demonstrating classic Institutional Absorption, shrugging off the recent late-August resignation of its CFO while maintaining a highly constructive technical posture. The stock's Quiet Accumulation and Perfect Stack signals confirm that buyers are focused on the underlying fundamentals, specifically the recent Q2 report that highlighted 11% YoY growth in Total Recurring Contract Value and a 60% pipeline expansion. Supported by a Risk-On macro regime where equity internals are aggressively bidding strong micro-stories despite geopolitical noise, NRC is positioned for high-conviction price discovery.

Fired Signals

STEADY CLIMBGOLDEN CROSSPERFECT STACKQUIET ACCUMULATIONSMA BOUNCE

Key Takeaways

Fundamental strength is overriding executive turnover, with double-digit recurring revenue growth and strong Q2 bookings driving institutional accumulation.
Technical signals (Steady Climb, Perfect Stack) point to constrained selling pressure and structural accumulation despite headline risks.
The Risk-On macro regime provides a strong tailwind, as calm credit markets allow investors to prioritize fundamental growth over geopolitical and idiosyncratic noise.

← Back to 2026-09-08 View Full NRC History →Yahoo Finance &nearr;